| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications
|
Kratz, Jeremy D.
|
|
2016
|
30 |
1 |
p. 33-39
|
artikel
|
| 2 |
Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis
|
Yeang, Calvin
|
|
2016
|
30 |
1 |
p. 75-85
|
artikel
|
| 3 |
Experimental Biology for the Identification of Causal Pathways in Atherosclerosis
|
Guo, Yanhong
|
|
2016
|
30 |
1 |
p. 1-11
|
artikel
|
| 4 |
Experimental Biology for the Identification of Causal Pathways in Atherosclerosis
|
Guo, Yanhong
|
|
|
30 |
1 |
p. 1-11
|
artikel
|
| 5 |
Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease
|
Stein, Evan A.
|
|
2016
|
30 |
1 |
p. 101-108
|
artikel
|
| 6 |
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
|
Kronenberg, Florian
|
|
2016
|
30 |
1 |
p. 87-100
|
artikel
|
| 7 |
Identifying new Risk Markers and Potential Targets for Coronary Artery Disease: The Value of the Lipidome and Metabolome
|
Laaksonen, Reijo
|
|
2016
|
30 |
1 |
p. 19-32
|
artikel
|
| 8 |
Identifying new Risk Markers and Potential Targets: The Value of the Proteome
|
Kontush, Anatol
|
|
2016
|
30 |
1 |
p. 13-18
|
artikel
|
| 9 |
Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection
|
Rosenson, Robert S.
|
|
2016
|
30 |
1 |
p. 65-74
|
artikel
|
| 10 |
Mendelian Randomization and Type 2 Diabetes
|
Swerdlow, Daniel I.
|
|
2016
|
30 |
1 |
p. 51-57
|
artikel
|
| 11 |
Mendelian Randomization for the Identification of Causal Pathways in Atherosclerotic Vascular Disease
|
Jansen, Henning
|
|
2016
|
30 |
1 |
p. 41-49
|
artikel
|
| 12 |
Pharmacogenomics to Revive Drug Development in Cardiovascular Disease
|
Dubé, Marie-Pierre
|
|
2016
|
30 |
1 |
p. 59-64
|
artikel
|
Tijdschrift beschrijving